Noritomo Itami

2.7k total citations
25 papers, 697 citations indexed

About

Noritomo Itami is a scholar working on Nephrology, Surgery and Molecular Biology. According to data from OpenAlex, Noritomo Itami has authored 25 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 6 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Noritomo Itami's work include Dialysis and Renal Disease Management (8 papers), Renal Diseases and Glomerulopathies (4 papers) and Hydrogen's biological and therapeutic effects (4 papers). Noritomo Itami is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Renal Diseases and Glomerulopathies (4 papers) and Hydrogen's biological and therapeutic effects (4 papers). Noritomo Itami collaborates with scholars based in Japan and United States. Noritomo Itami's co-authors include Yasuo Takekoshi, Toshiyuki Ohta, Sadayoshi Ito, Ryoichi Nakazawa, Masaaki Nakayama, Hiromi Hamada, Takashi Igarashi, Tetsushi Ogawa, Takashi Sakano and Hideki Nakano and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Pediatrics.

In The Last Decade

Noritomo Itami

24 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noritomo Itami Japan 16 335 240 133 91 69 25 697
Martin Kirschstein Germany 13 294 0.9× 147 0.6× 86 0.6× 73 0.8× 86 1.2× 28 1.0k
R. Morrison Hurley United States 15 221 0.7× 108 0.5× 122 0.9× 29 0.3× 65 0.9× 46 728
Lothar Volbracht Germany 14 149 0.4× 257 1.1× 54 0.4× 27 0.3× 74 1.1× 21 791
Rita D. Swinford United States 17 335 1.0× 188 0.8× 194 1.5× 50 0.5× 33 0.5× 37 976
Miyeun Han South Korea 16 263 0.8× 146 0.6× 117 0.9× 81 0.9× 80 1.2× 73 720
Benan Kasapoğlu Türkiye 15 104 0.3× 125 0.5× 81 0.6× 98 1.1× 187 2.7× 45 633
Giovanni Piotti Italy 12 131 0.4× 196 0.8× 90 0.7× 55 0.6× 44 0.6× 21 509
Hua-Chang Fang Taiwan 18 285 0.9× 213 0.9× 135 1.0× 32 0.4× 190 2.8× 33 859
Hassib Chehade Switzerland 15 326 1.0× 81 0.3× 140 1.1× 80 0.9× 109 1.6× 60 896
Juan J. Olivero United States 14 312 0.9× 212 0.9× 100 0.8× 47 0.5× 67 1.0× 51 822

Countries citing papers authored by Noritomo Itami

Since Specialization
Citations

This map shows the geographic impact of Noritomo Itami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noritomo Itami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noritomo Itami more than expected).

Fields of papers citing papers by Noritomo Itami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noritomo Itami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noritomo Itami. The network helps show where Noritomo Itami may publish in the future.

Co-authorship network of co-authors of Noritomo Itami

This figure shows the co-authorship network connecting the top 25 collaborators of Noritomo Itami. A scholar is included among the top collaborators of Noritomo Itami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noritomo Itami. Noritomo Itami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinugasa, Eriko, Ken Igawa, Hisaki Shimada, et al.. (2021). Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study. Clinical and Experimental Nephrology. 25(8). 875–884. 29 indexed citations
2.
3.
Nakayama, Masaaki, Noritomo Itami, Hodaka Suzuki, et al.. (2018). Novel haemodialysis (HD) treatment employing molecular hydrogen (H2)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study. Scientific Reports. 8(1). 254–254. 33 indexed citations
4.
Nakayama, Masaaki, Noritomo Itami, Hodaka Suzuki, et al.. (2017). Possible clinical effects of molecular hydrogen (H2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation. PLoS ONE. 12(9). e0184535–e0184535. 13 indexed citations
5.
Watanabe, Yuzo, Hideki Kawanishi, Kazuyuki Suzuki, et al.. (2015). JapaneseSociety forDialysisTherapyClinicalGuideline for “Maintenance Hemodialysis: Hemodialysis Prescriptions”. Therapeutic Apheresis and Dialysis. 19(S1). 67–92. 76 indexed citations
6.
Watanabe, Yuzo, Hideki Hirakata, Kazuyoshi Okada, et al.. (2015). Proposal for the Shared Decision‐Making Process Regarding Initiation and Continuation of Maintenance Hemodialysis. Therapeutic Apheresis and Dialysis. 19(S1). 108–117. 19 indexed citations
7.
Hattori, Motoshi, Akira Matsunaga, Yuko Akioka, et al.. (2012). Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan. Clinical and Experimental Nephrology. 17(4). 582–588. 7 indexed citations
8.
Nakayama, Masaaki, Hideki Nakano, Hiromi Hamada, et al.. (2010). A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial. Nephrology Dialysis Transplantation. 25(9). 3026–3033. 78 indexed citations
9.
Ohta, Toshiyuki, Takashi Sakano, Takashi Igarashi, Noritomo Itami, & Tetsushi Ogawa. (2004). Exercise-induced acute renal failure associated with renal hypouricaemia: results of a questionnaire-based survey in Japan. Nephrology Dialysis Transplantation. 19(6). 1447–1453. 75 indexed citations
10.
Hoshii, Sakurako, et al.. (2000). Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatric Nephrology. 14(4). 275–279. 32 indexed citations
11.
Furuyama, Hideto, et al.. (1999). Effective treatment of cyclic thrombocytopenia with cepharanthin. Pediatrics International. 41(5). 584–585. 4 indexed citations
12.
Ashikaga, Ryuichiro, et al.. (1997). FLAIR appearance of Wernicke encephalopathy.. PubMed. 15(4). 251–3. 16 indexed citations
14.
Sano, Hitomi, et al.. (1995). Microcephaly and early-onset nephrotic syndrome ?confusion in Galloway-Mowat syndrome. Pediatric Nephrology. 9(6). 711–714. 20 indexed citations
15.
Kusunoki, Yukihiro, Yasushi Akutsu, Noritomo Itami, et al.. (1991). Urinary Excretion of Terminal Complement Complexes in Glomerular Disease. ˜The œNephron journals/Nephron journals. 59(1). 27–32. 23 indexed citations
16.
Takekoshi, Yasuo, et al.. (1991). Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy.. PubMed. 35. S34–9. 43 indexed citations
17.
Goto, Yu‐ichi, et al.. (1990). Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. The Journal of Pediatrics. 116(6). 904–910. 70 indexed citations
18.
Akutsu, Yasushi, et al.. (1990). IgA nephritis in Behçet's disease: case report and review of the literature.. PubMed. 34(2). 52–5. 13 indexed citations
19.
Itami, Noritomo. (1990). Acute Tubulointerstitial Nephritis With Uveitis. Archives of Internal Medicine. 150(3). 688–688. 8 indexed citations
20.
Kusunoki, Yukihiro, et al.. (1989). Glomerular Deposition of C4 Cleavage Fragment (C4d) and C4-Binding Protein in Idiopathic Membranous Glomerulonephritis. ˜The œNephron journals/Nephron journals. 51(1). 17–19. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026